In October 2026, the world's largest gathering devoted to aging science will convene at Harvard University, marking a quiet but consequential threshold in human history: the science of longevity has crossed from philosophical aspiration into the language of drug pipelines and institutional capital. The 13th Aging Research & Drug Discovery Meeting brings together researchers, pharmaceutical giants, venture capitalists, and entrepreneurs not merely to share knowledge, but to build the collaborative architecture that turns biological understanding into medicines people can actually take. What was